Procept BioRobotics Corp (NASDAQ: PRCT) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Procept BioRobotics Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Procept BioRobotics Corp is $4.72B. A total of 0.71 million shares were traded on the day, compared to an average of 780.30K shares.

In the most recent transaction, Zadno Reza sold 26,423 shares of PRCT for 97.22 per share on Dec 04 ’24. After the transaction, the President, CEO now owns 152,762 company shares. In a previous transaction on Dec 04 ’24, Nouri Alaleh sold 28,092 shares at 97.13 per share. PRCT shares that EVP, CLO, CORP. SEC. owns now total 52,472.

Among the insiders who bought shares, REZA ZADNO acquired of 26,423 shares on Dec 04 ’24 at a per-share price of $96.48. In another insider transaction, Alalah Nouri bought 56,185 shares at $97.70 per share on Dec 04 ’24.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, PRCT has a high of $103.81 and a low of $41.75.

As of this writing, PRCT has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.44.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PRCT’s latest balance sheet shows that the firm has $304.32M in Cash & Short Term Investments as of fiscal 2021. There were $54.10M in debt and $16.24M in liabilities at the time. Its Book Value Per Share was $4.63, while its Total Shareholder’s Equity was $267.09M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRCT is Buy with a score of 4.60.

Most Popular

Related Posts